On May 25, 2022, Imexpharm Corporation announces the appointment of Mrs. Han Thi Khanh Vinh – member of BOD as Head of Internal Audit Subcommittee and Risk Management Department to replace Mr. Tran Anh Tuan from May 24, 2022.